IP Library Assignment 055189/0032
Patent Assignment
Reel/Frame 055189/0032

Assignment of Assignor's Interest

Recorded: 2021-02-09 Pages: 9
Assignor
TABUTEAU, HERRIOT
Executed: 2020-11-24
Assignee
ANTECIP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties (20)
Bupropion as a Modulator of Drug Activity
Application: 63/002,132 →
Bupropion and Dextromethorphan for Treating Agitation in Alzheimer's Disease
Application: 63/016,178 →
Bupropion as a Modulator of Drug Activity
Application: 63/032,517 →
Bupropion as a Modulator of Drug Activity
Application: 63/032,567 →
Bupropion as a Modulator of Drug Activity
Application: 63/077,606 →
Bupropion as a Modulator of Drug Activity
Application: 63/078,190 →
Combination of Dextromethorphan and Bupropion for Treating Depression
Application: 17/066,310 →
Publication: US US20210379054A9
Bupropion as a Modulator of Drug Activity
Application: 17/068,309 →
Publication: US US20210023075A1
Bupropion as a Modulator of Drug Activity
Application: 17/070,706 →
Publication: US US20210023076A1
Bupropion as a Modulator of Drug Activity
Application: 17/071,925 →
Publication: US US20210030750A1
Bupropion as a Modulator of Drug Activity
Application: 17/075,189 →
Publication: US US20210030751A1
Bupropion as a Modulator of Drug Activity
Application: 17/087,890 →
Publication: US US20210046067A1
Bupropion as a Modulator of Drug Activity
Application: 17/092,968 →
Publication: US US20210052521A1
Bupropion as a Modulator of Drug Activity
Application: 17/095,256 →
Publication: US US20220062275A9
Bupropion as a Modulator of Drug Activity
Application: 17/097,486 →
Bupropion as a Modulator of Drug Activity
Application: 17/099,226 →
Publication: US US20210069128A1
Bupropion as a Modulator of Drug Activity
Application: 16/950,838 →
Publication: US US20220031691A9
Bupropion as a Modulator of Drug Activity
Application: 16/952,759 →
Publication: US US20210069125A1
Bupropion as a Modulator of Drug Activity
Application: 17/100,456 →
Publication: US US20210077428A1
Bupropion as a Modulator of Drug Activity
Application: 17/103,819 →
Publication: US US20210077429A1
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 18, 2021
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 055318/0301 →